Drug
ASP8062 clinical trials
Also written ASP8062.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Astellas Pharma Global Development, Inc. (4) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · Astellas Pharma Inc (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ASP8062 is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With FibromyalgiaCompletedPhase 2Astellas Pharma Global Development, Inc.NCT03092726Written as ASP8062
- Human Laboratory Study of ASP8062 for Alcohol Use DisorderCompletedPhase 2National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT05096117Written as ASP8062
- A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use DisorderCompletedPhase 1Astellas Pharma Global Development, Inc.NCT04447287Written as ASP8062
- A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use DisorderWithdrawnPhase 2Astellas Pharma Global Development, Inc.NCT05062577Written as ASP8062
- A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult SubjectsCompletedPhase 1Astellas Pharma Global Development, Inc.NCT04003402Written as ASP8062
- Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female SubjectsCompletedPhase 1Astellas Pharma IncNCT03183739Written as ASP8062
Codes
What other systems call ASP8062 · ClinicalTrials.gg INT001378
- MeSH (NLM) C000709210ASP8062One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000709210 | ASP8062 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.